Merck and Bayer's heart drug vericiguat meets primary efficacy endpoint in Phase 3 study March 28, 2020 admin Trading Ideas Comments Off on Merck and Bayer's heart drug vericiguat meets primary efficacy endpoint in Phase 3 study …read more Source:: Yahoo Finance Did you enjoy this article? Join our FREE Newsletter! I agree to have my personal information transfered to MailChimp ( more information ) Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.We hate spam. Your email address will not be sold or shared with anyone else.